CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 25.50
+0.30 (1.19%)
Sep 11, 2026, 1:30 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 4.95 billion as of September 11, 2026. Its market cap has decreased by -45.04% in one year.
Market Cap
4.95B
Enterprise Value
9.59B
Revenue
4.65B
Ranking
n/a
PE Ratio
21.92
Stock Price
25.50
ChartMarket Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 4.95B, a decrease of -50.00%. That is a compound annual growth rate of -4.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.95B | -34.23% |
| Dec 31, 2025 | 7.52B | 7.82% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 530.47B |
| Caliway Biopharmaceuticals | 123.65B |
| Lin BioScience | 97.28B |
| Pell Bio-Med Technology | 69.45B |
| Cenra | 4.93B |
| St.Shine Optical | 4.90B |
| Ever Fortune.AI | 4.89B |
| Medigen Biotechnology | 4.87B |